Closing Bell: Arch Biopartners Inc down on Wednesday (ARCH)

Arch Biopartners Inc opened trading today at $1.54 and closed at $1.48. It traded at a low of $1.48 to a high of $1.54.

Shares dipped -1.99% from the previous day's close of $1.51.

During the day across North America, the TSX Composite closed -0.45% at 21880.95, the S&P 500 closed -0.77% at 5199.50, the Dow Jones Industrial Average closed -0.60% at 38763.45 and the Nasdaq Composite closed 1.03% at 16366.85.

Arch Biopartners Inc traded under ARCH on the Toronto Venture Exchange (TSX-V).

Trading volume was 4,040 on 18 total trades, with an average volume of 17,288 in the last five days.

Trading across the entire TSX-V saw 1,858 price advancers against 3,319 declines and 108 unchanged.

During the prior 52 weeks, ARCH.VN has traded as high as $2.56 (March 18,2024) and low as $0.97 (November 03,2023). Moreover, in the last 52 weeks, Arch Biopartners Inc's shares have shrunken -30.19 percent, while in 2024, they have dipped 0.00%.

It announced a 0.05 dividend on January 01/70, with an December 05/89 ex-date and January 01/70 pay day.

Following today's trading, Arch Biopartners Inc has a market capitalization of $97.62 million on a float of 64,651 shares outstanding. Its annual EPS is $-0.03.

Arch Biopartners Inc is a TSX Biotechnology company headquartered in Toronto, CAN.

Currently, Arch Biopartners Inc has an average recommendation of "Strong Sell" based on 0.00 analysts according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..